Michigan Diabetes Research and Training Center
Pilot and Feasibility Study (P/FS) Program Guidelines
ELIGIBILITY
Individuals who have full-time instructional, clinical, or research faculty positions at the University of Michigan or the Centers regional partner institutions (Michigan State University, Wayne State University or the University of Toledo) are eligible to apply as Principal Investigators of P/FS grant proposals. Biomedical and type 1 translational researchers at the University of Michigan faculty or at a regional partner institution may apply for funding through the Michigan Diabetes Research Center (MDRC, PI Martin G. Myers Jr., MD, PhD). Type 2 translational studies are restricted to researchers at the University of Michigan who may apply for funding through the Michigan Center for Diabetes Translational Research (MCDTR; PI William H. Herman, MD, MPH). Grant proposals should address key questions in the pathogenesis, diagnosis, prevention, or control of diabetes, its complications, or related endocrine or metabolic disorders (for example: counter-regulatory proteins, obesity, metabolic syndrome).
Eligible applicants must be: a) new investigators beginning careers in diabetes-related research (i.e. research relevant to diabetes, its complications, or related endocrine and metabolic disorders); b) established investigators in areas other than diabetes who wish to focus their expertise on a problem in diabetes-related research; or c) established investigators in diabetes-related research who wish to take an entirely new direction in their diabetes-related research. This new direction cannot be an extension of the research currently being undertaken by the applicant.
APPLICATIONS
Proposals should be for one year of support, with requested funding up to $50,000. P/FS support can be applied to supplies or to the salary of a study coordinator, research assistant or trainee. P/FS funds may not be used to support the salary of the Principal Investigator, for travel expenses, or to purchase equipment (i.e., durable items costing over $5,000).
Each proposal will be peer reviewed by recognized experts in the area of the proposal from non-participating university investigators from the United States and abroad. The results of the review will be weighed by the Grants Program Advisory Council at its meeting in November 2013. It is anticipated that the 6-7 most meritorious P/FS projects will be funded in January 2014.
Applications must be prepared using the 2013-14 MDRC/MCDTR P/F application. The application form may be downloaded below.
Proposals should be for one year of support, with requested funding up to $50,000.
Application Due Date: Monday August 5, 2013 (5 PM)
MDRTC/MCDTR PILOT and FEASIBILITY AWARD TERMS
- Awardees are required to inform the awarding Center if the P/FS grant receives external funding during the project period.
- A final progress report is due one month after the close of the project period. The one page report must contain a synopsis of scientific progress; a list of resulting collaborations, publications, grants; and a description of the relationship of the project to core use.
- For the following five years, awardees must provide annual updates concerning other support, publications, and research activities directly related to the P/FS grant award, even if they leave the institution.
- Biomedical and type 1 translational researcher awardees must attend the MDRC Annual Symposium (generally held in March or April each year) and present a poster on their research.
- Publications resulting from the MDRC funding must acknowledge grant support: NIH P60DK020572. Publications resulting from MCDTR funding must acknowledge grant support: NIH P30DK092926.
- Publications that utilized core facilities of either the MDRC or MCDTR must acknowledge grant support from the appropriate Center as follows:
“This work utilized ____ Core(s) of the Michigan Diabetes Research Center funded by NIH P60DK020572 from the National Institute of Diabetes and Digestive and Kidney Diseases.”
or
“This work utilized the ____ Core(s) of the Michigan Center for Diabetes Translational Research funded by NIH P30DK092926 from the National Institute of Diabetes and Digestive and Kidney Diseases.”